Larimar Therapeutics director Thomas O. Daniel not standing for re-election at 2022 Annual Meeting

Larimar Therapeutics, Inc.

Thomas O. Daniel, Ph.D., notified the Board he will not stand for re-election as a Class II director at the 2022 Annual Meeting.
His departure is effective at the conclusion of the Annual Meeting; no reason given other than not standing for re-election.
No disagreement with the Company's operations, policies, or practices.
Dr. Daniel served on the Board and any committees; no replacement named yet.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Thomas O. Daniel

Class II director

LRMR · Larimar Therapeutics, Inc.

Filed: April 11, 2022, 7:59 PM ET

On April 6, 2022, Thomas O. Daniel, Ph.D., a member of the Board of Directors (the “ Board ”) of Larimar Therapeutics, Inc. (the “ Company ”), notified the Company that he will not stand for re-election as a Class II director at the Company’s 2022 Annual Meeting of Stockholders (the “ Annual Meeting ”), and therefore, will no longer serve as a director of the Company or on any committee of the Board, effective as of the conclusion of the Annual Meeting.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Thomas O. Daniel departed as Class II director at Larimar Therapeutics, Inc..

Action: not stand for re-election
Role: Class II director

Exact text from the filing

On April 6, 2022, Thomas O. Daniel, Ph.D., a member of the Board of Directors (the “ Board ”) of Larimar Therapeutics, Inc. (the “ Company ”), notified the Company that he will not stand for re-election as a Class II director at the Company’s 2022 Annual Meeting of Stockholders (the “ Annual Meeting ”), and therefore, will no longer serve as a director of the Company or on any committee of the Board, effective as of the conclusion of the Annual Meeting.

View on SEC.gov

Larimar Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-22-101650

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.